£226k
+39%vs Mar 2025Active14771294Private limited companyStevenage
ASHA PHARMA LTD
Significant control: Shilpeshkumar Kanubhai Patel (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Asha Pharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Asha Pharma Ltd sell?
Registered activity: Other human health activities (SIC 86900). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ASHA PHARMA LTD is an active private limited company (company number 14771294) incorporated on 31 March 2023, registered in Stevenage. Its registered activity is other human health activities (SIC 86900). Latest small accounts cover the period ending 31 March 2026, showing net assets of £226k and cash of £14k, with 1 employee on average. Net assets rose 39% on the prior period (£163k). Across the last 3 periods on record the net-asset trend is rising.
Peer position · net assets
By net assets it sits in the top quarter of 600 comparable companies in Hertfordshire (median £1,844, upper quartile £20k).
02
Ownership and control
- Mr Shilpeshkumar Kanubhai Patel
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 31 March 20233 yrs ago
- Next accounts due
- 31 December 2027in 433 days
- Confirmation statement due
- 14 April 2027in 172 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£14k
+11%vs Mar 2025Not reported
1
−67%vs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £226k | £14k | £66k | — | — | — | 1 |
| 31 March 2025 | £163k | £13k | £37k | £44k | — | — | 3 |
| 31 March 2024 | £98k | £17k | £6,435 | £40k | — | — | 2 |
Cash per employee£14kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £226,406 at 31 March 2026
- Net assets up 10% or more on the prior period+38.7% vs prior period
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 31 March 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 433 days
- Confirmation statement duein 172 days
- Accounts period endNet assets £226k · small accounts
- Accounts period endNet assets £163k · small accounts
- Accounts period endNet assets £98k · small accounts
- Incorporated
08
Similar companies in Hertfordshire
- FERITA CONSULTANCY SERVICES LTDShefford · inc. Mar 2023
- CROWN PERSONNEL SERVICES LIMITEDHarpenden · inc. Apr 2023
- RESPAIR THERAPY C.I.C.Baldock · inc. Apr 2023
- RAIW MOBILE BUSINESS LINK LTDStevenage · inc. Apr 2023
- ZURAB LTDHatfield · inc. Apr 2023
- NEURO PHYSIO CONNECT LTDHitchin · inc. Mar 2023
All companies incorporated on 31 March 2023 · in Mar 2023.
09
Reminders for ASHA PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.